Identification of genes expressed in tumor-associated macrophages

Immunobiology

Volumn 207, Issue 5, 2003, Pages 351-359

  Gottfried, Eva ^a   Faust, Stefan ^a   Fritsche, Jana ^a   Kunz Schughart, Leoni A ^a   Andreesen, Reinhard ^a   Miyake, Kensuke ^b   Kreutz, Marina ^a  

^a UNIVERSITY OF REGENSBURG   (Germany)

^b SAGA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOXYPEPTIDASE; CD14 ANTIGEN; CD16 ANTIGEN; CELL MARKER; DIFFERENTIATION ANTIGEN; HLA DR ANTIGEN; MONOCYTE CHEMOTACTIC PROTEIN; PROLINE DIPEPTIDASE; RNA; TOLL LIKE RECEPTOR;

ARTICLE; CELL CONTACT; CELL CULTURE; CELL DIFFERENTIATION; CELL ISOLATION; CELL POPULATION; CELLULAR IMMUNITY; CONTROLLED STUDY; DIFFERENTIAL DISPLAY; DOWN REGULATION; GENE EXPRESSION; GENE IDENTIFICATION; HUMAN; HUMAN CELL; LEUKOCYTE ACTIVATION; MACROPHAGE ACTIVATION; MACROPHAGE FUNCTION; MICROENVIRONMENT; PHENOTYPIC VARIATION; PRIORITY JOURNAL; PROTEIN FAMILY; TUMOR ASSOCIATED LEUKOCYTE; TUMOR CELL; TUMOR IMMUNOLOGY; TUMOR SPHEROID; UPREGULATION;

EID: 0141996581     PISSN: 01712985     EISSN: None     Source Type: Journal    
DOI: 10.1078/0171-2985-00246     Document Type: Article

References (30)

1. Andreesen R, Picht J and Lohr GW. 1983. Primary cultures of human blood-born macrophages grown on hydrophobic teflon membranes. J. Immunol. Methods 56: 295-304.
2. Andreesen R, Bross KJ, Osterholz J and Emmrich F. 1986. Human macrophage maturation and heretogeneity: analysis with a newly generated set of monoclonal antibodies to differentiation antigens. Blood 67: 1257-1264.
3. Andreesen R, Scheibenbogen C, Brugger W, Krause S, Meerpohl HG, Leser HG, Engler H and Lohr GW. 1990. Adoptive transfer of tumor cytotoxic macrophages generated in vitro from circulating blood monocytes: a new approach to cancer immunotherapy. Cancer Res. 50: 7450-7456.
4. Begum NA, Tsuji S, Nomura M, Shida K, Azuma I, Hayashi A, Matsumoto M, Seya T and Toyoshima K. 1999. Human MD-1 homologue is a BCG-regulated gene product in monocytes: its identification by differential display. Biochem. Biophys. Res. Comm. 256: 325-329.
5. Carlsson J and Yuhas JM. 2002. Liquid-overlay culture of cellular spheroids. Recent Results Cancer Res. 95: 1-23.
6. Chen Z, Gordon JR, Zhang X and Xiang J. 2002. Analysis of the gene expression profiles of immature versus mature bone marrow-derived dendritic cells using DNA arrays. Biochem. Biophys. Res. Comm. 290: 66-72.
7. Elgert KD, Alleva DG and Mullins DW. 1998. Tumor-induced immune dysfunction: the macrophage connection. J. Leukoc. Biol. 64: 275-290.
8. Fugier-Vivier I, de Bouteiller O, Guret C, Fossiez F, Banchereau J, Mattei MG, Ait-Yahia S, Garcia E, Lebecque S and Liu YJ. 1997. Molecular cloning of human RP105. Eur. J. Immunol. 27: 1824-1827.
9. Gonwa TA, Frost JP and Karr RW. 1986. All human monocytes have the capability of expressing HLA-DQ and HLA-DP molecules upon stimulation with interferon-gamma. J. Immunol. 137: 519-524.
10. Jänicke R and Männel DN. 1990. Distinct tumor cell membrane constituents activate human monocytes for tumor necrosis factor synthesis. J. Immunol. 144: 1144-1150.
11. Konur A, Kreutz M, Krüchel R, Krause SW and Andreesen R. 1996. Three-dimensional co-culture of human monocytes and macrophages with tumor cells: analysis of macrophage differentiation and activation. Int. J. Cancer 66: 645-652.
12. Konur A, Kreutz M, Knüchel R, Krause SW and Andreesen R. 1998. Cytokine repertoire during maturation of monocytes to macrophages within spheroids of malignant and non-malignant urothelial cells. Int. J. Cancer 78: 648-653.
13. Krause SW, Rehli M, Kreutz M, Schwarzfischer L, Paulauskis JD and Andreesen R. 1996. Differential screening identifies genetic markers of monocyte to macrophage maturation. J. Leukoc. Biol. 60: 540-545.
14. Kunz-Schughart LA, Kreutz M, Knuechel R. 1998. Multicellular spheroids: a three-dimensional in vitro culture system to study tumour biology. Int. J. Exp. Pathol. 79: 1-23.
15. Laskin DL, Kimura T, Sakakibara S, Riley DJ and Berg RA. 1986. Chemotactic activity of collagen-like polypeptides for human peripheral blood neutrophils. J. Leukoc. Biol. 39: 255-266.
16. Laskin DL, Soltys RA, Berg RA and Riley DJ. 1994. Activation of alveolar macrophages by native and synthetic collagen- like polypeptides. Am. J. Respir. Cell Mol. Biol. 10: 58-64.
17. Mantovani A, Bottazzi B, Colotta F, Sozzani S and Ruco L. 1992. The origin and function of tumor-associated macrophages. Immunol. Today 13: 265-270.
18. Masters JR, Hepburn PJ, Walker L, Highman WJ, Trejdosiewicz LK, Povey S, Parkar M, Hill BT, Riddle PR and Franks LM. 1986. Tissue culture model of transitional cell carcinoma: characterization of twenty-two human urothelial cell lines. Cancer Res. 46: 3630-3636.
19. Miura Y, Miyake K, Yamashita Y, Shimazu R, Copeland NG, Gilbert DJ, Jenkins NA, Inazawa J, Abe T and Kimoto M. 1996. Molecular cloning of a human RP105 homologue and chromosomal localization of the mouse and human RP105 genes (Ly64 and LY64). Genomics 38: 299-304.
20. Miura Y, Shimazu R, Miyake K, Akashi S, Ogata H, Yamashita Y, Narisawa Y and Kimoto M. 1998. RP105 is associated with MD-1 and transmits an activation signal in human B cells. Blood 92: 2815-2822.
21. Miyake K, Shimazu R, Kondo J, Niki T, Akashi S, Ogata H, Yamashita Y, Miura Y and Kimoto M. 1998. Mouse MD-1, a molecule that is physically associated with RP105 and positively regulates its expression. J. Immunol. 161: 1348-1353.
22. Nagai Y, Shimazu R, Ogata H, Akashi S, Sudo K, Yamasaki H, Hayashi S, Iwakura Y, Kimoto M and Miyake K. 2002. Requirement for MD-1 in cell surface expression of RP105/CD180 and B-cell responsiveness to lipopolysaccharide. Blood 99: 1699-1705.
23. Palka JA and Phang JM. Prolidase in human breast cancer MCF-7 cells. 1998. Cancer Lett. 127: 63-70.
24. Stevenson HC, Miller P, Akiyama Y, Favilla T, Beman JA, Herberman R, Stull H, Thurman G, Maluish A and Oldham R. 1983. A system for obtaining large numbers of cryopreserved human monocytes purified by leukapheresis and counter-current centrifugation elutriation (CCE). J. Immunol. Methods 62: 353-363.
25. Sutherland RM. 1988. Cell and environment interactions in tumor microregions: the multicell spheroid model. Science 240: 177-184.
26. Tanoue A, Endo F and Matsuda I. 1990. The human prolidase gene: structure and restriction fragment length polymorphisms. J. Inherit. Metab. Dis.13: 771-774.
27. van Ravenswaay C, Kluin PM and Fleuren GJ. 1992.Tumor infiltrating cells in human cancer. On the possible role of CD16+macrophages in antitumor cytotoxicity. Lab. Invest. 67: 166-174.
28. Yamashita Y, Miyake K, Miura Y., Kaneko Y, Yagita H, Suda T, Nagata S, Nomura J, Sakaguchi N and Kimoto M. 1996. Activation mediated by RP105 but not CD40 makes normal B cells susceptible to anti-IgM-induced apoptosis: a role for Fc receptor coligation. J. Exp. Med. 184: 113-120.
29. Zarember KA and Godowski PJ. 2002. Tissue expression of human Toll-like receptors and differential regulation of Toll-like receptor mRNAs in leukocytes in response to microbes, their products, and cytokines. J. Immunol. 168: 554-561.
30. Ziegler-Heitbrock HW and Ulevitch RJ. 1993. CD14: cell surface receptor and differentiation marker. Immunol. Today 14: 121-125.